Search

everythinglearnresearchcommunity

for

Search:↓

Thallium exposure can cause serious health issues, including nerve damage and hair loss.

Tigason improved hair growth in a boy with monilethrix without side effects.

Methotrexate and azathioprine can help treat alopecia areata.

Minocycline reduces acne rash, pyridoxine lowers hand-foot syndrome risk, and scalp cooling lessens hair loss from cancer treatments.

Asynchronous telemedicine for acne treatment is effective and improves access and productivity.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Thyroxine can adjust the body's peripheral clock, potentially helping treat clock-related diseases.

Some drugs can cause hair loss or growth, but hair usually returns to normal after stopping the drug.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Alopecia is a key indicator of thallium poisoning.

Herbal drugs show promise for treating alopecia with fewer side effects, but standardization is challenging.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

All four treatments for early rheumatoid arthritis had similar safety profiles.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

Dupilumab may cause hair loss in some patients with severe atopic dermatitis.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

A man with multiple autoimmune diseases developed liver injury from azathioprine, but his liver improved after stopping the drug.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

Both treatments improved alopecia areata, but methotrexate caused more skin darkening, while triamcinolone caused skin lightening and thinning.

Children with alopecia areata, especially with Down syndrome or thyroid issues, should be screened for thyroid disease.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

The combination therapy may be more effective for mild alopecia areata, especially in patients with allergies.

TH07 is a topical combination of finasteride, latanoprost, and minoxidil, and shows promise.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Low-dose methotrexate effectively regrows hair in many alopecia areata patients but can cause some side effects.

Patients with alopecia areata on ritlecitinib responded well to tetanus and meningococcal vaccines.

Use some skin medications with caution during pregnancy; avoid strong steroids, certain eczema treatments, and systemic retinoids, but many topical treatments and nasal sprays are safe.